Indonesia considers prosecutions over cough syrup suspected of links to child deaths
Authorities have temporarily banned sales of some syrup-based medications and identified the presence in some products of ethylene…
Author
AstraZeneca drug fails one main goal in study of chronic immune disease
Despite the setback from the trial, AstraZeneca said it would continue to analyse the complete data set, which included 210…
Novartis to uphold generic drug supply despite surging energy costs
The generic drugmakers’ association in Europe last month warned that production of some medicines may have to be stopped because…
Biogen raises annual profit forecast for second straight quarter
Data on the drug has been promising and Biogen and Eisai are expected to file for a US approval soon with a decision expected in…
US FDA authorises Novavax’s COVID vaccine as booster for adults
The regulator's decision is in addition to the earlier clearance for the vaccine as a primary two-shot regimen for those aged 12…
EMA recommends Moderna’s updated Omicron-tailored vaccine
The agency also authorised Pfizer-BioNTech's and Moderna's vaccines for children as young six months
Merck under formal investigation in France over thyroid drug
The ruling by a judge in the French city of Marseille did not concern in any way the new formula for the Levothyrox product, but…
Moderna says Omicron booster response stays high through three months
The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron
Q3 results: Johnson & Johnson beats estimates on demand for cancer drug
The company said it expects some impact of inflation to ease next year but higher costs of inventory manufactured in 2022 could…
US health regulator extends review of Biogen’s ALS drug
Biogen said it had submitted responses to the FDA's information requests, which the agency said would require additional time for…